Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.88 -0.01 (-0.15%)
At close: Nov 11, 2026 · 4:00 PM EST

Cartesian Therapeutics (RNAC) Return on Invested Capital [ROIC] (2021 - 2022)

Updated

Cartesian Therapeutics (RNAC) reported Return on Invested Capital [ROIC] of 3.30% for Q4 2022, up 3.30 percentage points from 0.00% a year earlier but down 7.06 percentage points from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) Return on Invested Capital [ROIC] (2021 - 2022) Analysis & Trends

For FY2022, Cartesian Therapeutics posted Return on Invested Capital [ROIC] of 17.28%, up 34.02 percentage points from FY2021.

  • By year, Return on Invested Capital [ROIC] came in at -16.73% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Cartesian Therapeutics 210.06 Mn -304.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 3.30%
Sep 30, 2022 10.37%
Dec 31, 2021 0.00%
API Access

Cartesian Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=RNAC&period=max&api_key=YOUR_API_KEY